Genocea Biosciences/ US3724274010 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
2022-03-03
Genocea to Host Fourth Quarter 2021 Corporate Update Conference Call & Webcast
GlobeNewswire
2022-02-11
Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference
GlobeNewswire
2022-01-12
APIE Therapeutics Augments Leadership Team with Addition of Chief Business Officer and Chief Medical...
GlobeNewswire
2021-10-21
Genocea to Host Third Quarter 2021 Corporate Update Conference Call & Webcast
GlobeNewswire
2021-09-13
Jennifer Herron, of ADC Therapeutics, Joins Genocea Biosciences' Board of Directors
GlobeNewswire
2021-08-09
Voyager Therapeutics Transforms Pipeline and Increases Investment in Next-Generation TRACER™ AAV Cap...
GlobeNewswire
2021-07-22
Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast
GlobeNewswire
2021-07-13
Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cel...
GlobeNewswire
2021-06-04
Genocea Presents Promising Long-term Results from GEN-009 Neoantigen Vaccine Phase 1 Trial at ASCO 2...
GlobeNewswire
2021-04-22
Genocea To Host First Quarter 2021 Corporate Update Conference Call & Webcast
GlobeNewswire
2021-04-10
Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021
GlobeNewswire
2021-04-06
Genocea to Present at the 20th Annual Needham Virtual Healthcare Conference